Vibrio vulnificus is a Gram-negative pathogenic bacterium that causes serious infections in humans and requires iron for growth. A clinical isolate, V. vulnificus M2799, secretes a catecholate siderophore, vulnibactin, that captures ferric ions from the environment. In the ferric-utilization system in V. vulnificus M2799, an isochorismate synthase (ICS) and an outer membrane receptor, VuuA, are required under low-iron conditions, but alternative proteins FatB and VuuB can function as a periplasmic-binding protein and a ferric-chelate reductase, respectively. The vulnibactin-export system is assembled from TolCV1 and several RND proteins, including VV1_1681. In heme acquisition, HupA and HvtA serve as specific outer membrane receptors and HupB is a sole periplasmic-binding protein, unlike FatB in the ferric-vulnibactin utilization system. We propose that ferric-siderophore periplasmic-binding proteins and ferric-chelate reductases are potential targets for drug discovery in infectious diseases.
CITATION STYLE
Miyamoto, K., Kawano, H., Okai, N., Hiromoto, T., Miyano, N., Tomoo, K., … Tsujibo, H. (2021, December 1). Iron-Utilization System in Vibrio vulnificus M2799. Marine Drugs. Multidisciplinary Digital Publishing Institute (MDPI). https://doi.org/10.3390/md19120710
Mendeley helps you to discover research relevant for your work.